Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer
Neoadjuvant Therapy
DOI:
10.3233/cbm-160578
Publication Date:
2016-04-05T15:55:05Z
AUTHORS (5)
ABSTRACT
OBJECTIVE: We aimed to explore the potential application of circulating microRNA-451 (miR-451) in serum predicting resistance neoadjuvant chemotherapy (NACT) breast cancer (BC). METHODS: Eighty-two BC patients who underwent NACT were rec
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (48)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....